AALL1732
OPEN TO ACCRUAL
Phase 3 Inotuzumab Ozogamicin for Newly Dx HR B ALL plus MPAL and Disseminated B LLy
AAML1831
OPEN TO ACCRUAL
Phase 3 Study for AML Comparing Standard Therapy to CPX-351 plus Gilteritinib for FLT3
ACCL1931
OPEN TO ACCRUAL
Ph3 Levocarnitine Prophylaxis for AYA in ALL Therapy
ALTE2131
OPEN TO ACCRUAL
Ph3 Triptorelin and Protection of Ovarian Reserve in AYA with Cancer
APAL2020SC
OPEN TO ACCRUAL
PedAL Screening Trial - Developing new therapies for Relapsed Leukemias.
ARAR2331
OPEN TO ACCRUAL
Prospective Treatment of Types I, II and III Pleuropulmonary Blastoma (PPB)
PIDTC6906
OPEN TO ACCRUAL
PIDTC6906 A Study of PIRD Disorder
UW25098
OPEN TO ACCRUAL
Exploring Adolescent Patient Experiences in Receiving Blinatumomab